Study record

The unexplored Nexus: Mitochondria derived microproteins and Parkinson's disease

Patel K, Soni R, Shah J · Pathol Res Pract · 2025

ReviewSeveralEvidence tier R

What this study reported

Reviewed the literature on mitochondria-derived microproteins, including humanin, small humanin-like peptides and MOTS-c, in relation to Parkinson's disease pathogenesis. Summarised their reported involvement in mitochondrial dysfunction, oxidative stress, neuroinflammation and impaired autophagy across cell and animal models, and identified them as candidate targets for further mechanistic research.

Limitations

Narrative review with no stated search strategy, inclusion criteria or risk-of-bias assessment; MOTS-c is covered only as one of several peptides and the underlying evidence is preclinical.

Study record

Annotated fields for this study
Study modelReview
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
SpeciesNot reported
System studiedNarrative review of mitochondria-derived microproteins (humanin, SHLPs, MOTS-c) in Parkinson's disease
PopulationNot reported
DesignNarrative review
Sample size as reportedNot reported
Control groupNot reported
Route (data field only)Not reported
Endpoints measuredmitochondrial dysfunction; oxidative stress; neuroinflammation; autophagy; dopaminergic neuron degeneration
Pathways measuredOxidative stress · Inflammation · Autophagy / mitophagy
Research areasNervous system · Mitochondrial biology
Evidence tierR — Review (context, not evidence)
Publication typesJournal Article, Review

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Indirect
Model applicability
n/a
Sample size
n/a
Controls
n/a
Outcome validity
n/a
Support for its own conclusion
Weak

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.